Electrophysiologic HV-interval as a Predicor for Permanent Pacemaker Implantation After TAVI
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01801098|
Recruitment Status : Completed
First Posted : February 28, 2013
Last Update Posted : November 13, 2013
The development of a high grade AV-block is a frequent complication associated with transcatheter aortic valve implantation (TAVI). Patients who were suitable for TAVI will be enrolled in this study. The HV-interval will be determined before and immediately after implantation.
The hypothesis is that a prolonged HV-interval is associated with a high rate of complete AV-block following TAVI.
|Condition or disease|
|Symptomatic Aortic Valve Stenosis|
|Study Type :||Observational|
|Actual Enrollment :||25 participants|
|Official Title:||Electrophysiologic HV-interval as a Predicor for Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation With a Self-expanding Bioprosthesis|
|Study Start Date :||December 2012|
|Actual Primary Completion Date :||November 2013|
|Actual Study Completion Date :||November 2013|
- Determination of HV interval [ Time Frame: Changes in Baseline to 24 hours ]HV-interval will be determined by a 5F quadripolar electrode catheter with a CRD-2 curve configuration. Intracardiac signals will be assessed and determined before and after implantation.
- AV-block development after 1 month, 6 months and 12 months [ Time Frame: 1 month, 6 months and 12 months ]
- cardiovascular mortality [ Time Frame: 1 month, 6 months and 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01801098
|Division of Cardiology, Pulmonary Diseases, Vascular Medicine, University Hospital Duesseldorf|
|Duesseldorf, NRW, Germany, 40225|
|Principal Investigator:||Malte Kelm, MD||Division of Cardiology, Pulmonary Diseases, Vascular Medicine, University Hospital Duesseldorf|
|Principal Investigator:||Marc W. Merx, MD||Division of Cardiology, Pulmonary Diseases, Vascular Medicine University Hospital Duesseldorf|
|Principal Investigator:||Dong-In Shin, MD||Division of Cardiology, Pulmonary Diseases, Vascular Medicine, University Hospital Duesseldorf|